Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 INDUSTRY INSIGHTS: EUROPE NASAL SPRAY MARKET
5.1 INDUSTRY INSIGHTS
6 REGULATIONS: EUROPE NASAL SPRAY MARKET
6.1 REGULATORY SCENARIO IN EUROPE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN INFECTION AND ALLERGIC CASES
7.1.2 RISING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
7.1.3 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
7.1.4 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY
7.2 RESTRAINTS
7.2.1 PRODUCT RECALLS
7.2.2 ADVERSE EFFECTS OF USING NASAL SPRAYS
7.3 OPPORTUNITIES
7.3.1 NEW RISING DEMAND FOR SELF-ADMINISTRATIVE DRUG DELIVERY
7.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
7.3.3 STRATEGIC INITIATIVES TAKEN BY KEY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 REGULATORY HURDLES
7.4.2 ADDICTION TO NASAL SPRAY
8 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 DECONGESTION NASAL SPRAY
8.3 STEROID NASAL SPRAY
8.4 SALT WATER SOLUTION/SALINE NASAL SPRAY
8.5 OTHERS
9 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN
9.1 OVERVIEW
9.2 PUMP BOTTLES
9.3 PRESSURIZED CANISTERS
10 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM
10.1 OVERVIEW
10.2 MULTI DOSE
10.3 UNIT/SINGLE DOSE
10.4 BI DOSE
11 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
11.1 OVERVIEW
11.2 ANTIHISTAMINE
11.3 NASAL STEROIDS
11.4 MAST CELL INHIBITOR
11.5 ANTICHOLINERGIC
12 EUROPE NASAL SPRAY MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 NASAL CONGESTION
12.3 ALLERGIC AND NON-ALLERGIC RHINITIS
12.4 CENTRAL NERVOUS SYSTEM DISORDERS
12.5 VACCINATION
12.6 OTHERS
13 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
13.1 OVERVIEW
13.2 PRESCRIBED
13.3 OVER THE COUNTER
14 EUROPE NASAL SPRAY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOME CARE SETTINGS
14.3 HOSPITALS
14.4 CLINICS
14.5 COMMUNITY HEALTH CARE
15 EUROPE NASAL SPRAY MARKET, BY REGION
15.1 EUROPE
15.1.1 GERMANY
15.1.2 U.K.
15.1.3 FRANCE
15.1.4 ITALY
15.1.5 SPAIN
15.1.6 SWITZERLAND
15.1.7 NETHERLANDS
15.1.8 BELGIUM
15.1.9 RUSSIA
15.1.10 TURKEY
15.1.11 REST OF EUROPE
16 EUROPE NASAL SPRAY MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GLAXOSMITHKLINE PLC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 PFIZER INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 EMERGENT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 SANDOZ INTERNATIONAL GMBH (A PART OF NOVARTIS)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 CATALENT, INC.
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AYTU HEALTH (A SUBSIDIARY OF AYTU BIOPHARMA, INC.)
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 AISHWARYA GROUP
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 ASSERTIO THERAPEUTICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 REVENUE ANALYSIS
18.8.3 PRODUCT PORTFOLIO
18.8.4 RECENT DEVELOPMENT
18.9 AURENA LABORATORIES.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 BAYER AG
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 COMPANY SHARE ANALYSIS
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPMENTS
18.11 CIPLA INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENT
18.12 J PHARMACEUTICALS.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENTS
18.13 LEEFORD HEALTHCARE LTD
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENTS
18.14 ST. RENATUS.
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD)
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 ULTRATECH INDIA LIMITED
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 VIATRIS INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 COMPANY SHARE ANALYSIS
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 EUROPE STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 EUROPE SALT WATER SOLUTION/SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 EUROPE OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 7 EUROPE PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 EUROPE PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 10 EUROPE MULTI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 EUROPE UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 14 EUROPE ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE NASAL STEROIDS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE NASAL CONGESTION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 25 EUROPE PRESCRIBED IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE OVER THE COUNTER IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 EUROPE HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE CLINICS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 33 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 35 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 36 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 37 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 39 EUROPE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 GERMANY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 GERMANY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 42 GERMANY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 43 GERMANY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 44 GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 45 GERMANY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 46 GERMANY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 U.K. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 49 U.K. NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 50 U.K. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 51 U.K. NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 U.K. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 53 U.K. NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 FRANCE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 FRANCE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 56 FRANCE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 57 FRANCE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 58 FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 FRANCE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 60 FRANCE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 ITALY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 ITALY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 63 ITALY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 64 ITALY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 65 ITALY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 ITALY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 67 ITALY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 68 SPAIN NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 69 SPAIN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 70 SPAIN NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 71 SPAIN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 72 SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 SPAIN NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 74 SPAIN NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 75 SWITZERLAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 SWITZERLAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 77 SWITZERLAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 78 SWITZERLAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 79 SWITZERLAND NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 SWITZERLAND NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 81 SWITZERLAND NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 NETHERLANDS NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 NETHERLANDS NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 84 NETHERLANDS NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 85 NETHERLANDS NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 86 NETHERLANDS NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 NETHERLANDS NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 88 NETHERLANDS NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 BELGIUM NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 BELGIUM NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 91 BELGIUM NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 92 BELGIUM NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 93 BELGIUM NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 94 BELGIUM NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 95 BELGIUM NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 RUSSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 RUSSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 98 RUSSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 99 RUSSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 100 RUSSIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 101 RUSSIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 102 RUSSIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 103 TURKEY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 TURKEY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION)
TABLE 105 TURKEY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION)
TABLE 106 TURKEY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION)
TABLE 107 TURKEY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 TURKEY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION)
TABLE 109 TURKEY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 REST OF EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 EUROPE NASAL SPRAY MARKET: SEGMENTATION
FIGURE 2 EUROPE NASAL SPRAY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE NASAL SPRAY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE NASAL SPRAY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE NASAL SPRAY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE NASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE NASAL SPRAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE NASAL SPRAY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE NASAL SPRAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE NASAL SPRAY MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN INFECTION AND ALLERGIC CASES IS EXPECTED TO DRIVE THE EUROPE NASAL SPRAY MARKET IN THE FORECAST PERIOD
FIGURE 12 THE DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NASAL SPRAY MARKET IN 2023 AND 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE NASAL SPRAY MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR EUROPE NASAL SPRAY MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE NASAL SPRAY MARKET
FIGURE 16 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE, 2022
FIGURE 17 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 18 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 19 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 EUROPE NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2022
FIGURE 21 EUROPE NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2023-2030 (USD MILLION)
FIGURE 22 EUROPE NASAL SPRAY MARKET: BY CONTAINER DESIGN, CAGR (2023-2030)
FIGURE 23 EUROPE NASAL SPRAY MARKET: BY CONTAINER DESIGN, LIFELINE CURVE
FIGURE 24 EUROPE NASAL SPRAY MARKET: BY DOSAGE FORM, 2022
FIGURE 25 EUROPE NASAL SPRAY MARKET: BY DOSAGE FORM, 2023-2030 (USD MILLION)
FIGURE 26 EUROPE NASAL SPRAY MARKET: BY DOSAGE FORM, CAGR (2023-2030)
FIGURE 27 EUROPE NASAL SPRAY MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 28 EUROPE NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2022
FIGURE 29 EUROPE NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2023-2030 (USD MILLION)
FIGURE 30 EUROPE NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, CAGR (2023-2030)
FIGURE 31 EUROPE NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, LIFELINE CURVE
FIGURE 32 EUROPE NASAL SPRAY MARKET: BY APPLICATION, 2022
FIGURE 33 EUROPE NASAL SPRAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 34 EUROPE NASAL SPRAY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 35 EUROPE NASAL SPRAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 36 EUROPE NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2022
FIGURE 37 EUROPE NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, 2023-2030 (USD MILLION)
FIGURE 38 EUROPE NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, CAGR (2023-2030)
FIGURE 39 EUROPE NASAL SPRAY MARKET: BY PRESCRIPTION/AVAILABILITY, LIFELINE CURVE
FIGURE 40 EUROPE NASAL SPRAY MARKET: BY END USER, 2022
FIGURE 41 EUROPE NASAL SPRAY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 42 EUROPE NASAL SPRAY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 43 EUROPE NASAL SPRAY MARKET: BY END USER, LIFELINE CURVE
FIGURE 44 EUROPE NASAL SPRAY MARKET: SNAPSHOT (2022)
FIGURE 45 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2022)
FIGURE 46 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 47 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 48 EUROPE NASAL SPRAY MARKET: PRODUCT TYPE (2023-2030)
FIGURE 49 EUROPE NASAL SPRAY MARKET: COMPANY SHARE 2022 (%)
